Aurinia Pharmaceuticals Future Growth
How is Aurinia Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Future Growth Score
2/6Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
56.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 262 | -15 | -40 | -32 | 6 |
12/31/2024 | 189 | -75 | -96 | -87 | 6 |
12/31/2023 | 137 | -125 | -121 | -100 | 8 |
9/30/2022 | 129 | -115 | -116 | -116 | N/A |
6/30/2022 | 88 | -157 | -147 | -141 | N/A |
3/31/2022 | 66 | -168 | -157 | -151 | N/A |
12/31/2021 | 46 | -181 | -165 | -158 | N/A |
9/30/2021 | 72 | -156 | -138 | -129 | N/A |
6/30/2021 | 58 | -148 | -125 | -117 | N/A |
3/31/2021 | 51 | -127 | -109 | -101 | N/A |
12/31/2020 | 50 | -103 | -77 | -70 | N/A |
9/30/2020 | 0 | -129 | -104 | -98 | N/A |
6/30/2020 | 0 | -110 | -83 | -82 | N/A |
3/31/2020 | 0 | -102 | -73 | -73 | N/A |
12/31/2019 | 0 | -88 | -64 | -64 | N/A |
9/30/2019 | 0 | -57 | -52 | -52 | N/A |
6/30/2019 | 0 | -52 | -51 | -51 | N/A |
3/31/2019 | 0 | -61 | -50 | -50 | N/A |
12/31/2018 | 0 | -53 | -52 | -52 | N/A |
9/30/2018 | 0 | -53 | -47 | -47 | N/A |
6/30/2018 | 0 | -48 | -44 | -44 | N/A |
3/31/2018 | 0 | -34 | -46 | -46 | N/A |
12/31/2017 | 0 | -71 | -41 | -41 | N/A |
9/30/2017 | 0 | -76 | -37 | -36 | N/A |
6/30/2017 | 0 | -70 | -32 | -32 | N/A |
3/31/2017 | 0 | -71 | -23 | -23 | N/A |
12/31/2016 | 0 | -23 | -19 | -19 | N/A |
9/30/2016 | 0 | -19 | -19 | -19 | N/A |
6/30/2016 | 0 | -17 | N/A | -20 | N/A |
3/31/2016 | 0 | -14 | N/A | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AUPH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AUPH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AUPH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AUPH's revenue (28.6% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: AUPH's revenue (28.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AUPH's Return on Equity is forecast to be high in 3 years time